Thanks to all of our members, including State... · 8 COVID-19 DIAGNOSTIC TESTING AS OF 08.05.2020...
Transcript of Thanks to all of our members, including State... · 8 COVID-19 DIAGNOSTIC TESTING AS OF 08.05.2020...
OUR PREMIUM MEMBERS OUR SELECT MEMBERS
Thanks to all of our members, including:
OUR PREMIUM MEMBERS OUR SELECT MEMBERS
Thanks to all of our members, including:
OUR PREMIUM MEMBERS OUR SELECT MEMBERS
Thanks to all of our members, including:
OUR PREMIUM MEMBERS OUR SELECT MEMBERS
Thanks to all of our members, including:
OUR PREMIUM MEMBERS OUR SELECT MEMBERS
Thanks to all of our members, including:
6
COVID-19 HEALTH & SAFETY
CONSIDERATIONS
PRESENTED TO
FOOD AND BEVERAGE WISCONSIN
AUGUST 6, 2020
7
John R. Raymond, Sr., MDPresident and CEO
Medical College of Wisconsin
8
COVID-19 DIAGNOSTIC TESTING AS OF 08.05.2020• Cumulative tests administered as of 08.05.2020: WI = 1,001,924; MKE = 196,791
- Negative WI 944,984
- Negative MKE 176,767
- Positive WI 56,940 (5.7% stable)
- Positive MKE 20,024 (10.2% stable)
- # of tests reported yesterday in Wisconsin= 16,139; Highest single daily total was 17,410 on 08.04.2020
• Testing capacity: Stable at 24,156 in Wisconsin. New concerns about supply chain!
- 83 laboratories currently testing. 24 planning to test
• Positive tests (# positive has been at or above 900 eight times in last two weeks)
- Wisconsin = 884 (5.2%); MKE = 172 (6.8% seven-day average)
- Numbers of positive tests and positivity rate are early indicators
- Previous highest daily positive tests: WI: 1,157 on 07.21.2020; MKE: 477 on 05.29.2020
Learn more at covid19.mcw.edu
08.06.2020
9
COVID-19 HOSPITAL METRICS AS OF 08.05.2020
• Number of cumulative hospitalizations: 4,826 (8.5% of positive tests)
• Wisconsin hospitalizations on 08.05.2020
- 330 inpatients - stable (high was 446 on 04.09.2020; low 235 on 07.04.2020)
- 112 in ICU – stable (high was 196 on 04.09.2020; low was 65 on 07.05.2020)
- Hospitalizations and ICU use are lagging indicators
• ICU capacity: available ICU beds – 302
• Ventilator capacity – 340 ventilated patients; 1,655 available
• PPE trends: Stable (most critical needs = gowns, goggles and paper masks)
Learn more at covid19.mcw.edu
08.06.2020
10
VARIOUS COVID-19 INDICATORS AS OF 08.05.2020• Death is a highly lagging indicator
• Deaths as a percentage of COVID-19 cases = 1.7%
• Cumulative deaths WI = 970 (rate is flat) MKE = 388 (rate is flat)
- Male: WI = 522 (53.8%) MKE = 207 (53.4%)
- Female: WI = 436 (46.2%) MKE = 181 (46.6%)
- Black/African American: WI = 209 (21.5%) MKE = 149 (38.4%)
- White: WI = 670 (69.1%) MKE = 168 (43.3%)
- Hispanic/Latinx: WI = 117 (12.0%) MKE = 56 (14.4%)
• Doubling time: WI = 35.4 days MKE = 43.1 days
• 7-day mean growth rate: WI = 1.6% MKE = 1.0%
• Reproductive number: WI = 0.97 MKE = 0.85 (early indicator)
Learn more at covid19.mcw.edu
08.06.2020
11
Learn more at covid19.mcw.edu
08.06.2020
TRACKING COVID-19 PANDEMIC TRAJECTORYMilwaukee Mask Mandate
07.17.2020
12
HOW DOES COVID-19 SPREAD
Three main routes of spread:• Most common is large respiratory droplet inhalation- Reduced by face coverings and distancing
• Probably spread by respiratory aerosols (indoors)- Can spread farther than 6 feet and can persist in air for hours
- Face coverings are less effective than for large respiratory droplets
- HVAC interventions: upward flow, maximize air exchanges, filter air
• Also spread by touch (secondary to respiratory droplets)- Reduced by handwashing and sanitization and keeping hands away from face
Learn more at covid19.mcw.edu
08.06.2020
13
DISTANCING WORKS FOR DROPLETS
Source: Chu et al. The Lancet, June 2, 2020
DOI: https://doi.org/10.1016/S0140-6736(20)31142
Learn more at covid19.mcw.edu
Distancing is probably less effective for aerosols
Infectious aerosols
08.06.2020
14
HOW DOES TESTING MITIGATE SPREAD OF COVID-19?
• It is estimated that half of COVID-19 transmissions are from individuals
with no symptoms or mild symptoms
• Testing results in earlier detection (pre-symptomatic or asymptomatic),
which allows earlier quarantine and isolation
• Early detection by testing means better treatment and triage
• Testing allows for contact tracing, earlier interventions and tighter testing
cycles for those exposed to an infected individual
• Testing allows earlier detection of outbreaks in neighborhoods,
workplaces, and congregate living situations
Learn more at covid19.mcw.edu
08.06.2020
15
OPTIONS FOR TESTING AND SCREENING
• RT-PCR COVID-19 RNA test
- Results are only good for the day employee was tested. Could perform pooled testing.
• Temperature checks
- Low sensitivity for asymptomatic patients. May be cumbersome. May expose the
individual performing the screening. Could demonstrate commitment to safety.
• Daily symptom self-screening before reporting to work
- Requires app or web-site.
• Serological tests for antibodies
- Limited value for return to work.
Learn more at covid19.mcw.edu
08.06.2020
16
Dose of COVID-19 inoculum is based on four contact parameters:
Number, proximity, intensity and duration of exposures
Number Intensity Duration
AVOID SINGING
Proximity
AVOID CROWDS
STAY AT HOME
AVOID SHOUTINGMAINTAIN DISTANCE LIMIT TIME OF EXPOSURE
LIMIT INDOOR ACTIVITIES
WEAR A FACE COVERING
WASH HANDS
WORK FROM HOME
NON-PHARMACOLOGICAL INTERVENTIONS: EMPLOYEE
Learn more at covid19.mcw.edu
08.06.2020
17
Dose of COVID-19 inoculum is based on four contact parameters:
Number, proximity, intensity and duration of exposures
Number Intensity Duration
SANITIZE SURFACES
Proximity
REDUCE WORKFORCE
DENSITY
FILTER AIR
VIRTUAL MEETINGS INCREASE AIR EXCHANGES
MANDATE FACE COVERINGS
PROVIDE HAND SANITIZER
MODIFY TRAFFIC FLOW
LIMIT CONGREGATING
CONTROL ACCESS POINTS
DAILY SCREENING
STAGGER SHIFTS
NON-PHARMACOLOGICAL INTERVENTIONS: EMPLOYER
KEEP INTERACTIONS BRIEF
LIMIT TRAVELREMOTE WORK
Learn more at covid19.mcw.edu
08.06.2020
18
THANK YOU VERY MUCH
QUESTIONS?
Learn more at covid19.mcw.edu
08.06.2020
OUR PREMIUM MEMBERS OUR SELECT MEMBERS
Thanks to all of our members, including:
20
Workforce Protection Through Proactive Testing
21
Flattening the curve
*4 Total Test Cycles To Date. Absenteeism and Positive Rates Remain Consistent.
30-Mar 9-Apr 19-Apr 29-Apr 9-May 19-May 29-May 8-Jun
Perc
ent
of
Pop
ula
tio
n In
fect
ed
Actual % positive
Est. % w/o prevention
2% 11% 16% 19% 10% 5% 3% <1%
Test Cycle 15.8% positive
Test Cycle 20.5% positive
Test Cycle 3*0.2% positive
Paid Sick Leave
100%
22
Who Are We?
CoVigilanceSalm Partners
• Smoked sausage supplier for Brands and Retailers
• Sharing the benefits of technology– Coextrusion, Cook-in-Pack
• Do not own a retail brand– We don’t compete with our
customers
• We Coordinate High-Volume COVID-19 Testing Solutions for Businesses and Institutions
• Initially Focused on the Food Industry After Designing the Testing Protocol for Salm
• Primarily in Wisconsin, But Have Executed Testing Protocols Nationwide
• Our Goal is to Find the Best Solutions Available Today for Our Clients
23
Salm Partners: Benefits For Our Customers
• Extended shelf life
• Superior food safety
• Clean label
• Waste reduction
• Consumer preferred
• Agility and scale
24
Our initial COVID-19 response
Engineering Controls
• IR temp checks
• Physical barriers
• Masks and shields
• Increase buses (x3)
Admin Controls
• Education & communication
• Social distancing
• Wellness screens
• Aggressive contact tracing / sick leave
• Plant layout and flow changes
• Audits
• Pay premiums not tied to attendance
Assess Vectors
• Transportation
• Entrance
• Workstations
• Breaks/Break Areas
• Hallways
• Exits
25
Wellness Screens
26
What Has Changed?
27
Physical Dividers & PPE
28
Preventative controls (e.g. masks, partitions, distancing) help reduce spread but there is ongoing spread outside our plant
Source: Dr. Melvin Sanicas
Decision To Test: Asymptomatic Spread
29
Round One: Test!
• 1st round of testing on April 24th
• Challenge: How to safely test 500 people and document?
• Nasopharyngeal Swab– aka “The Brain Tickler”
• No one tested was symptomatic
• 5.8% tested positive– Pre-symptomatic, asymptomatic,
post-infection
30
Mid-May Testing
• Switched to anterior nasal swabs
• Increased documentation automation
• Inline with CDC guidance, did not test previously positive individuals
• 0.5% positivity rate
31
Flattening the curve
*4 Total Test Cycles To Date. Absenteeism and Positive Rates Remain Consistent.
30-Mar 9-Apr 19-Apr 29-Apr 9-May 19-May 29-May 8-Jun
Perc
ent
of
Pop
ula
tio
n In
fect
ed
Actual % positive
Est. % w/o prevention
2% 11% 16% 19% 10% 5% 3% <1%
Test Cycle 15.8% positive
Test Cycle 20.5% positive
Test Cycle 3*0.2% positive
Paid Sick Leave
100%
32
Salm Partners: Lessons Learned
• Preventative controls seem to work– Masks, social distancing, hygiene
– Wellness screens
• Social distancing is not natural and difficult to maintain
– Audit, audit, audit
• Difference between positive and infectious– An employee may test “positive” for up to three months
• Testing takes a significant investment in process design– Social distancing, low wait times for testing, overhead burden
• Our partners appreciate the effort being made to protect them, their families, and their jobs
33
CoVigilance: Lessons Learned
• Speed To Response Is Crucial– If you’re waiting to smell smoke, you should at least be holding the fire extinguisher.
• View Testing As A Cost Of Doing Business– Testing Every 3 Weeks = ~$1/hr Increase In Labor Costs
• Testing Is Challenging, But Achievable– Treat this like a big problem. Do what hasn’t yet been done.
• Top-Level Buy-In Is The Make-Or-Break – A supportive culture and committed resources are necessary to achieve lasting
organizational change.
• Objectively Assess Employee Adherence to Preventative Measures– If you believe you have weak spots in your preventative controls, test...test…test.
• Listen To The Experts, Not The Talking Points
34
Q&A
OUR PREMIUM MEMBERS OUR SELECT MEMBERS
Thanks to all of our members, including:
OUR PREMIUM MEMBERS OUR SELECT MEMBERS
Thanks to all of our members, including:
OUR PREMIUM MEMBERS OUR SELECT MEMBERS
Thanks to all of our members, including: